Biogen Inc

BIIB•NASDAQ•HEALTHCARE

$202.19+1.57 (+0.78%)

+1.1% 30D•Market closed•Prev $200.62

+$16.24+8.7%

1 month

+1.3%

price return

Year to date

+13.7%

price return

Big funds

8

hold this stock

Key stats

Jul 26

Market cap: $29.85B
P/E: 21.6x

Forward P/E

14.4x

Beta

0.16

Volume

596.4K

52-week range

$124.56 - $219.72

Analysts

What do analysts expect?

Current

$202.19

Target

$227.59

+25.40 (+12.6%) possible upside12 months

Fundamentals

Business quality, value, and expectations at a glance.

Fundamentals

Is the business strong?

Reasonably priced and profitable.

Net margin: 13.8%
P/E: 21.56
Forward P/E: 14.37
Market cap: $29.9B

Valuation

P/S3.00
P/B1.59

Quality

Operating margin22.9%
ROE7.7%
ROA5.9%

Growth

Beta0.16

Smart money

Filed positions and reported activity tied to this stock.

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$9.2B

P
PRIMECAP
Q1 2026 13F
$2.7B
position
A
AQR
Q1 2026 13F
$346.2M
position
M
Millennium
Israel Englander · Q4 2025 13F
$198.1M
position
P
Point72
Steven Cohen · Q1 2026 13F
$148.4M
position
A
Alger
Q1 2026 13F
$134.4M
position

Show all 8 holders

B
BlackRock
Q1 2026 13F
$2.9B
position
FL
FMR LLC
Q1 2026 13F
$2.3B
position
JC

Checking federal contract awards

Coverage gaps for BIIBNo recent insider tradeNo recent market-voice mention

Technicals

Trend, range, and the price levels that matter.

Technicals

Price structure

This stock is in a strong uptrend.

Trend

Strong uptrend

80 / 100

RSI 14

46balanced

20D volatility

57%annualized

52-week range

$202.19

$124.56$219.72

20D support

$186.03recent floor

20D resistance

$219.72recent ceiling

Returns

5D -1.8%20D +0.1%60D +10.3%

Price vs moving averages

SMA20 -1.5%SMA50 +1.4%SMA200 +11.1%

Volume pace

1.34xvs prior 20D

JPMorgan Chase

Q1 2026 13F

$378.1M

position